Literature DB >> 33887136

Site-Specific Lipidation Enhances IFITM3 Membrane Interactions and Antiviral Activity.

Emma H Garst1,2, Hwayoung Lee3, Tandrila Das1,2, Shibani Bhattacharya4, Avital Percher1, Rafal Wiewiora2,5, Isaac P Witte1, Yumeng Li6, Tao Peng6, Wonpil Im3, Howard C Hang1,7.   

Abstract

Interferon-induced transmembrane proteins (IFITMs) are S-palmitoylated proteins in vertebrates that restrict a diverse range of viruses. S-palmitoylated IFITM3 in particular engages incoming virus particles, prevents their cytoplasmic entry, and accelerates their lysosomal clearance by host cells. However, how S-palmitoylation modulates the structure and biophysical characteristics of IFITM3 to promote its antiviral activity remains unclear. To investigate how site-specific S-palmitoylation controls IFITM3 antiviral activity, we employed computational, chemical, and biophysical approaches to demonstrate that site-specific lipidation of cysteine 72 enhances the antiviral activity of IFITM3 by modulating its conformation and interaction with lipid membranes. Collectively, our results demonstrate that site-specific S-palmitoylation of IFITM3 directly alters its biophysical properties and activity in cells to prevent virus infection.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33887136      PMCID: PMC9112659          DOI: 10.1021/acschembio.1c00013

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   4.634


  73 in total

1.  Palmitoylated calnexin is a key component of the ribosome-translocon complex.

Authors:  Asvin Kk Lakkaraju; Laurence Abrami; Thomas Lemmin; Sanja Blaskovic; Béatrice Kunz; Akio Kihara; Matteo Dal Peraro; Françoise Gisou van der Goot
Journal:  EMBO J       Date:  2012-02-07       Impact factor: 11.598

2.  S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.

Authors:  Jacob S Yount; Roos A Karssemeijer; Howard C Hang
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

3.  IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.

Authors:  Julian Buchrieser; Séverine A Degrelle; Thérèse Couderc; Quentin Nevers; Thierry Fournier; Marc Lecuit; Olivier Schwartz; Olivier Disson; Caroline Manet; Daniel A Donahue; Françoise Porrot; Kenzo-Hugo Hillion; Emeline Perthame; Marlene V Arroyo; Sylvie Souquere; Katinka Ruigrok; Anne Dupressoir; Thierry Heidmann; Xavier Montagutelli
Journal:  Science       Date:  2019-07-12       Impact factor: 47.728

4.  IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.

Authors:  Charles C Bailey; Guocai Zhong; I-Chueh Huang; Michael Farzan
Journal:  Annu Rev Virol       Date:  2014-11-01       Impact factor: 10.431

Review 5.  Expanding and reprogramming the genetic code of cells and animals.

Authors:  Jason W Chin
Journal:  Annu Rev Biochem       Date:  2014-02-10       Impact factor: 23.643

6.  Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.

Authors:  I-Chueh Huang; Charles C Bailey; Jessica L Weyer; Sheli R Radoshitzky; Michelle M Becker; Jessica J Chiang; Abraham L Brass; Asim A Ahmed; Xiaoli Chi; Lian Dong; Lindsay E Longobardi; Dutch Boltz; Jens H Kuhn; Stephen J Elledge; Sina Bavari; Mark R Denison; Hyeryun Choe; Michael Farzan
Journal:  PLoS Pathog       Date:  2011-01-06       Impact factor: 6.823

7.  Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Altering Mechanical Properties of Cell Membranes.

Authors:  Xiangyang Guo; Jan Steinkühler; Mariana Marin; Xiang Li; Wuyuan Lu; Rumiana Dimova; Gregory B Melikyan
Journal:  ACS Nano       Date:  2021-03-03       Impact factor: 18.027

8.  The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.

Authors:  Samad Amini-Bavil-Olyaee; Youn Jung Choi; Jun Han Lee; Mude Shi; I-Chueh Huang; Michael Farzan; Jae U Jung
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

9.  Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.

Authors:  Krishna C Suddala; Christine C Lee; Paul Meraner; Mariana Marin; Ruben M Markosyan; Tanay M Desai; Fredric S Cohen; Abraham L Brass; Gregory B Melikyan
Journal:  PLoS Pathog       Date:  2019-01-14       Impact factor: 6.823

10.  IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation.

Authors:  Diana C Yánez; Hemant Sahni; Susan Ross; Anisha Solanki; Ching-In Lau; Eleftheria Papaioannou; Alessandro Barbarulo; Rebecca Powell; Ulrike C Lange; David J Adams; Martino Barenco; Masahiro Ono; Fulvio D'Acquisto; Anna L Furmanski; Tessa Crompton
Journal:  Eur J Immunol       Date:  2018-11-09       Impact factor: 5.532

View more
  5 in total

Review 1.  Positive Regulation of the Antiviral Activity of Interferon-Induced Transmembrane Protein 3 by S-Palmitoylation.

Authors:  Shubo Wen; Yang Song; Chang Li; Ningyi Jin; Jingbo Zhai; Huijun Lu
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 2.  Chemical approaches for investigating site-specific protein S-fatty acylation.

Authors:  Emma H Garst; Tandrila Das; Howard C Hang
Journal:  Curr Opin Chem Biol       Date:  2021-07-29       Impact factor: 8.822

3.  S-palmitoylation and sterol interactions mediate antiviral specificity of IFITM isoforms.

Authors:  Tandrila Das; Xinglin Yang; Hwayoung Lee; Emma Garst; Estefania Valencia; Kartik Chandran; Wonpil Im; Howard Hang
Journal:  Res Sq       Date:  2021-12-29

Review 4.  Lessons in self-defence: inhibition of virus entry by intrinsic immunity.

Authors:  Saliha Majdoul; Alex A Compton
Journal:  Nat Rev Immunol       Date:  2021-10-13       Impact factor: 108.555

5.  Differential Transcriptomics Analysis of IPEC-J2 Cells Single or Coinfected With Porcine Epidemic Diarrhea Virus and Transmissible Gastroenteritis Virus.

Authors:  Lina Song; Jing Chen; Pengfei Hao; Yuhang Jiang; Wang Xu; Letian Li; Si Chen; Zihan Gao; Ningyi Jin; Linzhu Ren; Chang Li
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.